Exelixis (EXEL) Short Interest Ratio & Short Volume → How Biden has already won 2024 (From Porter & Company) (Ad) Free EXEL Stock Alerts $20.91 -0.32 (-1.51%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Exelixis Short Interest DataCurrent Short Volume9,570,000 sharesPrevious Short Volume8,620,000 sharesChange Vs. Previous Month+11.02%Dollar Volume Sold Short$224.51 millionShort Interest Ratio / Days to Cover4.0Last Record DateApril 30, 2024Outstanding Shares303,200,000 sharesFloat Size285,790,000 sharesShort Percent of Float3.35%Today's Trading Volume1,548,191 sharesAverage Trading Volume2,270,716 sharesToday's Volume Vs. Average68% Short Selling Exelixis ? Sign up to receive the latest short interest report for Exelixis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEXEL Short Interest Over TimeEXEL Days to Cover Over TimeEXEL Percentage of Float Shorted Over Time Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… Exelixis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,570,000 shares $224.51 million +11.0%3.4%4 $23.46 4/15/20248,620,000 shares $195.67 million +26.2%3.0%3.8 $22.70 3/31/20246,830,000 shares $162.08 million -17.2%2.3%2.9 $23.73 3/15/20248,250,000 shares $189.59 million -6.8%2.8%3.6 $22.98 2/29/20248,850,000 shares $193.82 million +5.7%3.0%4 $21.90 2/15/20248,370,000 shares $172.34 million +14.5%2.8%3.9 $20.59 Get the Latest News and Ratings for EXEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exelixis and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,310,000 shares $159.07 million -14.6%2.5%3.5 $21.76 1/15/20248,560,000 shares $194.31 million +5.6%2.8%3.7 $22.70 12/31/20238,110,000 shares $194.56 million -16.7%2.7%3.5 $23.99 12/15/20239,740,000 shares $228.01 million -0.7%3.2%4.3 $23.41 11/30/20239,810,000 shares $213.96 million +1.1%3.3%4.3 $21.81 11/15/20239,700,000 shares $205.93 million +4.8%3.2%4.2 $21.23 10/31/20239,260,000 shares $190.66 million +8.2%3.1%4 $20.59 10/15/20238,560,000 shares $182.84 million +6.3%2.8%3.7 $21.36 9/30/20238,050,000 shares $175.89 million -4.2%2.6%3.6 $21.85 9/15/20238,400,000 shares $183.20 million +6.6%2.7%3.8 $21.81 8/31/20237,880,000 shares $176.43 million -0.8%2.6%3.2 $22.39 8/15/20237,940,000 shares $171.19 million +23.7%2.6%3.2 $21.56 7/31/20236,420,000 shares $126.54 million +13.6%2.1%2.5 $19.71 7/15/20235,650,000 shares $109.55 million -9.9%N/A2.3 $19.39 6/30/20236,270,000 shares $119.82 million -8.7%N/A2.4 $19.11 6/15/20236,870,000 shares $131.22 million -3.2%N/A2.5 $19.10 5/31/20237,100,000 shares $136.89 million -4.2%N/A2.5 $19.28 5/15/20237,410,000 shares $144.50 million +21.5%N/A2.4 $19.50 4/30/20236,100,000 shares $111.63 million -9.9%N/A2 $18.30 4/15/20236,770,000 shares $131.74 million -4.9%N/A2.1 $19.46 3/31/20237,120,000 shares $138.20 million -11.4%N/A2.2 $19.41 3/15/20238,040,000 shares $143.11 million -11.6%N/A2.6 $17.80 2/28/20239,090,000 shares $155.26 million -14.3%N/A3.3 $17.08 2/15/202310,600,000 shares $188.36 million +0.9%N/A4.2 $17.77 1/31/202310,510,000 shares $185.19 million -7.0%N/A4.5 $17.62 1/15/202311,300,000 shares $185.66 million -2.6%N/A4.9 $16.43 12/30/202211,600,000 shares $186.06 million +3.8%N/A5.1 $16.04 12/15/202211,180,000 shares $176.64 million -3.8%N/A4.8 $15.80 11/30/202211,620,000 shares $198.47 million +12.1%N/A5.2 $17.08 11/15/202210,370,000 shares $174.22 million +9.2%N/A4.5 $16.80 10/31/20229,500,000 shares $157.51 million +1.7%N/A3.9 $16.58 10/15/20229,340,000 shares $146.17 million +3.1%N/A4 $15.65 9/30/20229,060,000 shares $142.06 million -3.6%N/A4.1 $15.68 9/15/20229,400,000 shares $161.02 million -3.5%N/A4.3 $17.13Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. EXEL Short Interest - Frequently Asked Questions What is Exelixis' current short interest? Short interest is the volume of Exelixis shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 9,570,000 shares of EXEL short. 3.35% of Exelixis' shares are currently sold short. Learn More on Exelixis' current short interest. What is a good short interest ratio for Exelixis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXEL shares currently have a short interest ratio of 4.0. Learn More on Exelixis's short interest ratio. Which institutional investors are shorting Exelixis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exelixis: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Exelixis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.35% of Exelixis' floating shares are currently sold short. Is Exelixis' short interest increasing or decreasing? Exelixis saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 9,570,000 shares, an increase of 11.0% from the previous total of 8,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exelixis' float size? Exelixis currently has issued a total of 303,200,000 shares. Some of Exelixis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exelixis currently has a public float of 285,790,000 shares. How does Exelixis' short interest compare to its competitors? 3.35% of Exelixis' shares are currently sold short. Here is how the short interest of companies compare to Exelixis: Halozyme Therapeutics, Inc. (6.69%), Repligen Co. (8.51%), Novavax, Inc. (32.00%), Charles River Laboratories International, Inc. (3.69%), National Research Co. (1.52%), Medpace Holdings, Inc. (3.72%), Precigen, Inc. (11.81%), Luna Innovations Incorporated (9.13%), Neurocrine Biosciences, Inc. (1.82%), Revolution Medicines, Inc. (7.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Exelixis stock? Short selling EXEL is an investing strategy that aims to generate trading profit from Exelixis as its price is falling. EXEL shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exelixis? A short squeeze for Exelixis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EXEL, which in turn drives the price of the stock up even further. How often is Exelixis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXEL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Halozyme Therapeutics Short Interest Repligen Short Interest Novavax Short Interest Charles River Laboratories International Short Interest National Research Short Interest Medpace Short Interest Precigen Short Interest Luna Innovations Short Interest Neurocrine Biosciences Short Interest Revolution Medicines Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXEL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings